Wohua Pharmaceutical said its 2026 first-nine-months revenue fell 5.73% YoY to 589 mln yuan. Net profit rose 44.78% YoY to 92.65 mln yuan; adjusted net profit (ex-items) rose 47.94% YoY to 90.65 mln yuan. Net cash from operating activities increased 11.63% YoY to 121 mln yuan. In Q3 2026, revenue dipped 1.89% YoY to 195 mln yuan, net profit rose 29.87% YoY to 25.09 mln yuan and adjusted net profit rose 33.19% YoY to 24.69 mln yuan.

2026-10-09

Wohua Pharmaceutical said its 2026 first-nine-months revenue fell 5.73% YoY to 589 mln yuan. Net profit rose 44.78% YoY to 92.65 mln yuan; adjusted net profit (ex-items) rose 47.94% YoY to 90.65 mln yuan. Net cash from operating activities increased 11.63% YoY to 121 mln yuan. In Q3 2026, revenue dipped 1.89% YoY to 195 mln yuan, net profit rose 29.87% YoY to 25.09 mln yuan and adjusted net profit rose 33.19% YoY to 24.69 mln yuan.